Skip to main content
Equibles

STVN · Stevanato Group S.p.A. · Metrics

Track STVN — free

Use STVN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research STVN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.49 -0.01 (-0.05%) At close · Oct 23
Rebalance outlook locked
Market Cap
$5.35B
Shares
273.00M
Volume · Oct 23 403.48K Avg daily vol (3M) 395.1K

STVN metrics

63 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$19.49
Market cap
$5.35B

Price action

20 metrics
Price change (1W)
+3.1%
Price change (30D)
-8.8%
Price change (3M)
-1.0%
Price change (6M)
+20.5%
Price change (YTD)
-3.1%
Price change (1Y)
-29.4%
Trailing year
Price change (5Y)
-21.6%
52-week high
$27.61
52-week low
$13.43
Change from 52-week high
-29.4%
Change from 52-week low
+45.1%
Annualized volatility
45.8%
Annualized volatility (3M)
31.9%
Beta
1.1
RSI (14D)
44.0
Price vs SMA 50
-6.1%
Price vs SMA 200
+7.5%
Avg volume (3M)
395,097
Relative volume
1.0
Average dollar volume
$8.18M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
273.00M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
3.1
reciprocal yield 32.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
29.0%
Operating margin
16.8%
Trailing 12 months
Net margin
11.8%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$4.91

Growth

11 metrics
Revenue growth YoY
+7.4%
Year over year
Net income growth YoY
+18.7%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+18.6%
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
+6.4%
Revenue CAGR (5Y)
+12.4%
EPS CAGR (3Y)
-1.9%
EPS CAGR (5Y)
+9.1%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-19.5%

Quality

14 metrics
Return on equity
9.4%
Return on assets
5.5%
Debt / equity
0.3
Current ratio
1.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$399.34M
Latest balance sheet
Cash & equivalents
$153.28M
Total assets
$2.99B
Total debt
$552.62M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
125
13F filer change QoQ
-10
Institutional ownership
16.4%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-0.3%
Holder tenure
12.4
Price vs estimated holder cost
-17.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.4%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
42 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$459,738
Insider-sentiment score
32 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1849853 CUSIP T9224W109 13F (30d) 19 filings 19 filers Visit website Investor relations